A Histologically Complete Response to Immunotherapy Using Pembrolizumab in a Patient with Giant Cell Carcinoma of the Lung: An Additional Report and Literature Review

We previously reported a case of giant cell carcinoma in the lung, in which the use of antiprogrammed death 1 (PD-1) immunotherapy resulted in substantial tumor reduction. In the present study, we describe an additional clinical course. A 69-year-old woman was diagnosed with giant cell carcinoma of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakimoto, Tomoo, Sasaki, Mamoru, Yamamoto, Tatsuya, Iwamaru, Arifumi, Ogata, Kentaro, Lee, Ko, Nakayama, Shingo, Minematsu, Naoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815550/
https://www.ncbi.nlm.nih.gov/pubmed/31737389
http://dx.doi.org/10.1155/2019/1763625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815550/
https://www.ncbi.nlm.nih.gov/pubmed/31737389
http://dx.doi.org/10.1155/2019/1763625

Ejemplares similares